search
Back to results

Efficiency of Art-therapy in Psychotic Disorders

Primary Purpose

Schizophrenia

Status
Terminated
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Art therapy
metacognitive therapy
Sponsored by
University Hospital, Strasbourg, France
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Schizophrenia focused on measuring Schizophrenia, Art-therapy, Visual organization

Eligibility Criteria

18 Years - 55 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • schizophrenia according to DSM IV

Exclusion Criteria:

  • addiction problem
  • invalidating visual sensory problems
  • neurological history

Sites / Locations

  • Service de psychiatrie, Hôpitaux Universitaires de Strasbourg

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Art-therapy

Metacognitive therapy

Arm Description

16 Art-therapy sessions

16 Metacognitive therapy sessions

Outcomes

Primary Outcome Measures

Change in Response times between baseline and after 16 therapy sessions

Secondary Outcome Measures

Change in Clinical scales (SAPS and SANS) between baseline and after 16 therapy sessions
Change in esthetic perception between baseline and after 16 therapy sessions
Esthetic Perception Test
Change in errors in visual organization tasks between baseline and after 16 therapy sessions

Full Information

First Posted
January 26, 2015
Last Updated
October 18, 2019
Sponsor
University Hospital, Strasbourg, France
search

1. Study Identification

Unique Protocol Identification Number
NCT02383095
Brief Title
Efficiency of Art-therapy in Psychotic Disorders
Official Title
Efficiency of Art-therapy in Psychotic Disorders
Study Type
Interventional

2. Study Status

Record Verification Date
October 2019
Overall Recruitment Status
Terminated
Why Stopped
Difficulties of recruitment
Study Start Date
May 27, 2015 (Actual)
Primary Completion Date
October 2019 (Actual)
Study Completion Date
October 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Strasbourg, France

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The main purpose of the protocol is to test the efficiency of art-therapy versus metacognitive rehabilitation on the visual perception disorders observed in patients with schizophrenia.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Schizophrenia
Keywords
Schizophrenia, Art-therapy, Visual organization

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
9 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Art-therapy
Arm Type
Experimental
Arm Description
16 Art-therapy sessions
Arm Title
Metacognitive therapy
Arm Type
Active Comparator
Arm Description
16 Metacognitive therapy sessions
Intervention Type
Behavioral
Intervention Name(s)
Art therapy
Intervention Type
Behavioral
Intervention Name(s)
metacognitive therapy
Primary Outcome Measure Information:
Title
Change in Response times between baseline and after 16 therapy sessions
Time Frame
Baseline and after 16 therapy sessions (up to 6 months)
Secondary Outcome Measure Information:
Title
Change in Clinical scales (SAPS and SANS) between baseline and after 16 therapy sessions
Time Frame
Baseline and after 16 therapy sessions (up to 6 months)
Title
Change in esthetic perception between baseline and after 16 therapy sessions
Description
Esthetic Perception Test
Time Frame
Baseline and after 16 therapy sessions (up to 6 months)
Title
Change in errors in visual organization tasks between baseline and after 16 therapy sessions
Time Frame
aseline and after 16 therapy sessions (up to 6 months)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: schizophrenia according to DSM IV Exclusion Criteria: addiction problem invalidating visual sensory problems neurological history
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Anne GIERSCH, PhD
Organizational Affiliation
Hôpitaux Universitaires de Strasbourg
Official's Role
Principal Investigator
Facility Information:
Facility Name
Service de psychiatrie, Hôpitaux Universitaires de Strasbourg
City
Strasbourg
ZIP/Postal Code
67091
Country
France

12. IPD Sharing Statement

Learn more about this trial

Efficiency of Art-therapy in Psychotic Disorders

We'll reach out to this number within 24 hrs